{
    "nctId": "NCT06603597",
    "briefTitle": "HER2-positive Breast Cancer Registry",
    "officialTitle": "Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)",
    "overallStatus": "RECRUITING",
    "conditions": "HER2 + Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "Overall survival rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Stage I-IV HER2-positive breast cancer\n\nExclusion Criteria:\n\n* None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}